Novel sequences represent the new area in drug development. These particular brief chains of amino units offer remarkable potential for targeting intractable processes involved in several diseases. Early research indicate these can achieve high binding and demonstrate promising bioavailability features, creating ways to novel therapies. Ongoing ana